Anticancer Drugs Sourced from Marine Life

Author(s): Ramasamy Santhanam*, Santhanam Ramesh*, Subbiah Balasundari* and Sheba R. David * .

DOI: 10.2174/9789815256055124010005

Marine Biota-based Anticancer Drug Candidates in Pipeline

Pp: 20-45 (26)

Buy Chapters

* (Excluding Mailing and Handling)

  • * (Excluding Mailing and Handling)

Abstract

SHS investigation development is considered from the geographical and historical viewpoint. 3 stages are described. Within Stage 1 the work was carried out in the Department of the Institute of Chemical Physics in Chernogolovka where the scientific discovery had been made. At Stage 2 the interest to SHS arose in different cities and towns of the former USSR. Within Stage 3 SHS entered the international scene. Now SHS processes and products are being studied in more than 50 countries.

Abstract

This chapter deals with the approved and marketed anticancer drugs derived from marine sponges, mollusks/cyanobacteria, and tunicates; marine biota-derived anticancer compounds in clinical trials i.e in III, II, and I phases; and bioactive new chemical entities (NCEs) with anticancer function from marine biota. Limiting factors in the development and approval of drugs from marine biota and significant challenges in the development and approval of marine drugs are also given.

We recommend

Favorable 70-S: Investigation Branching Arrow

Authors:Bentham Science Books